Table 3.
Within-group effect sizes (Cohen’s d) for secondary outcomes (ITT)
| |
Effect size (Cohen’s d) |
|||
|---|---|---|---|---|
| Baseline to EOT tr-MI |
Baseline to FU tr-MI |
Baseline to EOT TAU |
Baseline to FU TAU |
|
| WHO-5 | 0.58** | 0.61** | 0.06 | 0.18 |
| DSS-20 | 0.35 | 0.70*** | 0.31 | 0.41 |
| SDQ-20 | −0.01 | 0.10 | −0.04 | 0.28 |
| RAAS Close | 0.18 | 0.25 | 0.37* | 0.06 |
| RAAS Depend | 0.37* | 0.20 | 0.02 | 0.04 |
| RAAS Anxiety | 0.02 | 0.18 | 0.21 | −0.11 |
| RAAS Avoidant | 0.26 | 0.25 | −0.17 | 0.05 |
ITT: Intention to treat (N = 39/35), WHO-5: Well-being scale; DSS-20: Dissociative Symptoms Scale; SDQ-20: Somatic Dissociation Questionnaire; RAAS: Revised Adult Attachment Scale. Significance levels * p < .05, ** p < .01, *** p < .001 (constrained linear mixed model).